Michael Nagle / Bloomberg via Getty Images Shares of Eli Lilly (LLY) fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed first-quarter results that ...

Here’s an idea for the next episode of “The Eli Manning Show.” The former quarterback visits various investors and tries to pool enough money to buy a minority ownership stake in the Giants.

The organization retained Moelis & Company to help facilitate the arrangement, and shortly after the announcement, former Giants quarterback Eli Manning said he was interested in having an ...

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...

Will Jaxson Dart be the Giants’ next Eli Manning, after six mostly brutal seasons of Daniel Jones? Maybe. And if the second time is the charm for the Giants in their post-Manning years ...

In a video posted to the Giants' social media account, Eli Manning sent a congratulatory video to Dart after the latter met with media. Manning wished Dart well, and said he hopes to root for him ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

So, of course, it all immediately worked out. With the Braves tied in the eighth inning, Snitker elected to hit righty Eli White against Cardinals right-hander Ryan Fernandez. Now, White isn't ...

You can reach Katie on Signal at palmer.01. Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions ...